# Reduction of Pro-Inflammatory Synovial Fluid Biomarkers in Osteoarthritis of the Knee With Alpha-2 Macroglobulin

> **NCT03656575** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 75 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** synovial fluid biomarker concentrations

## Key facts

- **NCT ID:** NCT03656575
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2019-04-20
- **Final completion:** 2019-04-20
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2020-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03656575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03656575, "Reduction of Pro-Inflammatory Synovial Fluid Biomarkers in Osteoarthritis of the Knee With Alpha-2 Macroglobulin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03656575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*